Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase
Author(s) -
Subhashri Kundu,
Goran Biuković,
Gerhard Grüber,
Thomas Dick
Publication year - 2016
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01291-16
Subject(s) - bedaquiline , tryptophan synthase , protein subunit , atp synthase , biochemistry , bacteria , tryptophan , biology , chemistry , microbiology and biotechnology , tuberculosis , enzyme , mycobacterium tuberculosis , medicine , amino acid , genetics , gene , pathology
The tuberculosis drug bedaquiline inhibits mycobacterial F-ATP synthase by binding to its c subunit. Using the purified ε subunit of the synthase and spectroscopy, we previously demonstrated that the drug interacts with this protein near its unique tryptophan residue. Here, we show that replacement of ε's tryptophan with alanine resulted in bedaquiline hypersusceptibility of the bacteria. Overexpression of the wild-type ε subunit caused resistance. These results suggest that the drug also targets the ε subunit.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom